These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 26588695

  • 1. Adenosine-A1 receptor agonist induced hyperalgesic priming type II.
    Araldi D, Ferrari LF, Levine JD.
    Pain; 2016 Mar; 157(3):698-709. PubMed ID: 26588695
    [Abstract] [Full Text] [Related]

  • 2. Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
    Araldi D, Ferrari LF, Levine JD.
    J Neurosci; 2015 Sep 09; 35(36):12502-17. PubMed ID: 26354917
    [Abstract] [Full Text] [Related]

  • 3. Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.
    Araldi D, Ferrari LF, Levine JD.
    Pain; 2017 Jul 09; 158(7):1204-1216. PubMed ID: 28306605
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
    Khasar SG, Wang JF, Taiwo YO, Heller PH, Green PG, Levine JD.
    Neuroscience; 1995 Jul 09; 67(1):189-95. PubMed ID: 7477899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.
    Araldi D, Khomula EV, Ferrari LF, Levine JD.
    J Neurosci; 2018 Feb 28; 38(9):2226-2245. PubMed ID: 29431655
    [Abstract] [Full Text] [Related]

  • 10. Role of a novel nociceptor autocrine mechanism in chronic pain.
    Ferrari LF, Levine E, Levine JD.
    Eur J Neurosci; 2013 May 28; 37(10):1705-13. PubMed ID: 23379641
    [Abstract] [Full Text] [Related]

  • 11. Mu-opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat.
    Araldi D, Ferrari LF, Levine JD.
    Neuroscience; 2018 Dec 01; 394():60-71. PubMed ID: 30342200
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of Expression of Hyperalgesic Priming by Estrogen Receptor α in the Rat.
    Ferrari LF, Araldi D, Levine JD.
    J Pain; 2017 May 01; 18(5):574-582. PubMed ID: 28089711
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Shared mechanisms for opioid tolerance and a transition to chronic pain.
    Joseph EK, Reichling DB, Levine JD.
    J Neurosci; 2010 Mar 31; 30(13):4660-6. PubMed ID: 20357116
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia.
    Khomula EV, Araldi D, Levine JD.
    J Neurosci; 2019 Sep 04; 39(36):7061-7073. PubMed ID: 31300521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Systemic Morphine Produces Dose-dependent Nociceptor-mediated Biphasic Changes in Nociceptive Threshold and Neuroplasticity.
    Ferrari LF, Araldi D, Bogen O, Green PG, Levine JD.
    Neuroscience; 2019 Feb 01; 398():64-75. PubMed ID: 30529265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.